Development of prevention and repair of degenerative joint disorders with fluocinolone acetonide (FA).
| Project/Area Number |
15K20480
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Dental engineering/Regenerative dentistry
|
|---|
| Research Institution | Okayama University |
|---|
Principal Investigator |
|
|---|
| Research Collaborator |
KUBOKI Takuo (00225195)
ONO Mitsuaki (60613156)
Emilio Satoshi Hara (40779443)
|
|---|
| Project Period (FY) |
2015-04-01 – 2017-03-31
|
| Project Status |
Completed (Fiscal Year 2016)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2015: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
|---|
| Keywords | フルオシノロンアセトニド / 軟骨細胞分化 / 軟骨再生 / ヒト骨髄由来間葉系間質細胞 / ヒト骨髄由来間葉系間質細胞（hBMSCs） / フルオシノロンアセトニド（FA） |
|---|
| Outline of Final Research Achievements |
Osteoarthritis is the most common chronic condition of the joints, affecting approximately ten million Japanese and articular cartilage repair remains a challenging problem. Based on a high-throughput screening and functional analysis, we found that fluocinolone acetonide (FA) strongly potentiated chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs). In an in vivo cartilage defect model in knee joints of immunocompromised mice, transplantation of FA/TGF-b3 -treated hBMSCs could completely repair the articular surface.
|
Report
(3 results)
Research Products
(6 results)
